Inhalation Capsules Market to Reach $1.5 Billion Globally by 2032 at 6.4% CAGR: Allied Market Research 

The increasing prevalence of respiratory diseases, the growing patient preference for inhalation therapy, and the advances in inhalation capsule technology are projected to drive the global inhalation capsules market’s growth during the forecast period. The North America region is predicted to witness prominent growth by 2032.

Wilmington, New Castle, Delaware, March 27, 2024 (GLOBE NEWSWIRE) — Allied Market Research has recently published a report, titled, Inhalation Capsules Market Size, Share, Competitive Landscape and Trend Analysis Report by Type, by Application: Global Opportunity Analysis and Industry Forecast, 2023-2032.” According to the report, the global inhalation capsules market generated $822.4 million in 2022, and is anticipated to generate $1.5 billion by 2032, rising at a CAGR of 6.4% from 2023 to 2032. 

Prime Determinants of Growth 

The growing prevalence of respiratory diseases, rising demand for personalized medicine, and the increasing preference of patients for inhalation capsules are the factors expected to drive the growth of the global inhalation capsules market in the forecast period from 2023 to 2032. However, the risk of contamination and stability of drugs with inhalation capsules may hamper the market growth in the coming future. On the contrary, the continuous advancements in inhalation capsule technology and development of novel formulations are expected to offer remunerative opportunities for the expansion of the inhalation capsules market during the forecast period. 

Request Sample of the Report on Inhalation Capsules Market Forecast 2032 https://www.alliedmarketresearch.com/request-sample/A296225 

Report Coverage & Details: 

Report Coverage  Details 
Forecast Period  2023–2032 
Base Year  2022 
Market Size in 2022  $822.4 million 
Market Size in 2032  $1.5 billion 
CAGR  6.4% 
No. of Pages in Report  320 
Segments covered  Type, Application, and Region 
Drivers  Rising prevalence of respiratory diseases  Growth in patient preference for inhalation therapy  Increasing demand for personalized medicine 
Opportunities  Advancements in drug delivery technology  Development of novel inhalation capsule formulations 
Restraints  Stability of drugs and the risk of contamination 

Want to Explore More, Connect to our Analyst – https://www.alliedmarketresearch.com/connect-to-analyst/A296225 

Type: Gelatin Capsules Sub-segment to be the Most Dominant During the Forecast Period 

The gelatin capsules sub-segment accounted for the largest global inhalation capsules market share of 61.7% in 2022 and is expected to grow at the highest CAGR of 6.7% during the forecast period. This is mainly because gelatin capsules offer precise dose distribution, ensuring that patients receive the appropriate quantity of medicine with each inhalation. This precision is particularly crucial in respiratory medicine, where accurate dosage is essential for achieving therapeutic efficacy while maintaining safety. Additionally, the taste-masking properties of gelatin capsules, combined with the convenience of inhalation treatment, contribute to increased patient compliance. Furthermore, gelatin capsules improve the bioavailability of certain medications by enhancing their absorption in the respiratory system. 

Application: Asthma Treatment Sub-segment to Flourish Immensely During the Forecast Period 

The asthma treatment sub-segment accounted for the largest market share of 48.9% in 2022 and dominate in terms of market share by 2032. The sub-segment is expected to rise at the highest CAGR of 6.9% during the forecast period. This dominance is majorly because inhalation capsules provide a rapid and straightforward form of administration, making them highly effective for controlling acute asthma attacks. Their ease of use and portability allow patients to self-administer medication as needed, providing a sense of control over their condition. Additionally, the versatility of inhalation capsules allows for the administration of bronchodilators, corticosteroids, and combination therapies, enabling tailored treatment programs that consider individual patient characteristics and minimize systemic absorption of drugs, thereby reducing the risk of adverse effects. 

Region: North America Market to Hold Major Share by 2032 

The inhalation capsules market in the North America region accounted for the largest share of 32.8% in 2022 and is predicted to continue to maintain its dominance in terms of market share during the forecast period. This growth is mainly owing to the region’s extensive healthcare infrastructure and advanced medical research facilities, fostering the adoption of inhalation capsules. With a robust pharmaceutical sector, North America encourages research and development in inhalation technologies, leading to continuous advancements in inhalation devices and formulations. This innovative environment promotes the use of inhalation capsules as a cutting-edge and effective medication delivery strategy. Additionally, investments in research aim to enhance the aerodynamics of inhalation capsules, ensuring accurate and efficient medication delivery to the respiratory system. 

For Procurement Information – https://www.alliedmarketresearch.com/purchase-enquiry/A296225 

Leading Players in the Inhalation Capsules Market: 

  • Boehringer Ingelheim GmbH 
  • CHIESI Farmaceutici S.p.A. 
  • Cipla 
  • ACG Worldwide 
  • Capsugel 
  • AstraZeneca Plc 
  • Elpen S.A. 
  • Vectura Group plc. 
  • Qualicaps 
  • Novartis   

The report provides a detailed analysis of the key players of the global inhalation capsules market. These players have adopted different strategies, such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain their dominance in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario. 

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research: 

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports. 

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access 

About Allied Market Research: 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI. 

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.  

Contact 
David Correa 

1209 Orange Street, 

Corporation Trust Center, 

Wilmington, New Castle, 

Delaware 19801 USA. 

Toll Free: +1-800-792-5285 

Int’l: +1-503-894-6022 

UK: +44-845-528-1300 

Hong Kong: +852-301-84916 

India (Pune): +91-20-66346060 

Fax: +1-855-550-5975 

help@alliedmarketresearch.com   

Web: https://www.alliedmarketresearch.com    

Follow Us on: LinkedIn Twitter 

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy